Login
Join free
Add to favorites
中文
Home
|
Suppliers
|
Products
|
News
|
Events and Expos
|
About Us
Products
Products
Suppliers
News
Events/Expos
Let suppliers know what you want to buy!
Home
Suppliers
Products
News
New Products
Supplier News
Upcoming Events
Business
Web
Events and Expos
About Us
Products
Products
Suppliers
News
Events
Home
> Request Information
Title:
Tessa Therapeutics Announces Updated Safety, Efficacy and Biomarker Data from Phase 2 Trial of Autologous CD30.CAR-T Therapy (TT11)
*
Company:
*
Country:
Select your Country
China
Afghanistan
Albania
Algeria
Angola
Argentina
Aruba
Australia
Austria
Azerbaijan
Bahrain
Bangladesh
Belgium
Bolivia
Brazil
Brunei
Bulgaria
Burma
Burundi
Cambodia
Cameroon
Canada
Chad
Chile
Colombia
Congo
Costa Rica
Croatia
Cuba
Cyprus
Denmark
Djibouti
Dominica
Egypt
Estonia
Ethiopia
Fiji
Finland
France
Gabon
Gambia
Germany
Ghana
Greece
Guatemala
Guiana
Guinea
Haiti
Netherlands
Honduras
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Israel
Italy
Jamaica
Japan
Jordan
Kenya
North Korea
Kuwait
Kyrgyzstan
Laos
Lebanon
Liberia
Libya
Lithuania
Luxemburg
Malaysia
Maldives
Mauritania
Mauritius
Mexico
Monaco
Mongolia
Nepal
New Zealand
Nigeria
Norway
Pakistan
Panama
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Rwanda
Saudi Arabia
Singapore
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sudan
Sweden
Switzerland
Syria
Tanzania
Thailand
Tunisia
Turkey
Uganda
Ukiain
United Arab Emirates
United Kingdom
United States
Uruguay
Uzbekistan
Venezuela
Vietnam
Yemen
Yugoslavia
Zambia
Zimbabwe
Other Country
Mozambique
*
Name:
Job Title:
*
Tel:
Fax:
*
E-mail:
Message:
Verification Code:
refresh
中文
